Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of using a purified botulinum toxin
(Xeomin®, Merz, USA), the same injectable used to improve face wrinkles, to treat a specific
type of hair loss seen in men and women not associated with scarring or other internal
disease called 'pattern hair loss'. This type of hair loss is medically called 'androgenic or
androgenetic alopecia'. In men it is typically called 'male pattern baldness' whereas in
women it is called 'female pattern baldness' and in both cases is hereditary meaning there
will be a history of relatives that describe having the same condition.